Long-term exclusive zinc monotherapy in symptomatic Wilson disease: Experience in 17 patients

Hepatology

Volumn 50, Issue 5, 2009, Pages 1442-1452

  Linn, Francisca H H ^a,b,c   Houwen, Roderick H J ^a   Van Hattum, Jan ^d   Van Der Kleij, Stefan ^a   Van Erpecum, Karel J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c CENTRAL MILITARY HOSPITAL   (Netherlands)

^d Medical Centre Berg en Bosch   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; COPPER; GLUCONATE ZINC; ZINC ACETATE; ZINC SULFATE;

ADOLESCENT; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; DECOMPENSATED LIVER CIRRHOSIS; DETERIORATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GRANULOCYTOPENIA; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LONG TERM CARE; MACROCYTIC ANEMIA; MALE; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT RESPONSE; WILSON DISEASE;

ADOLESCENT; ADULT; BILIRUBIN; CHELATING AGENTS; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER; LONGITUDINAL STUDIES; MALE; METALLOTHIONEIN; PENICILLAMINE; TRACE ELEMENTS; TREATMENT OUTCOME; YOUNG ADULT; ZINC;

EID: 72949100331     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23182     Document Type: Article

References (17)

1. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. HEPATOLOGY 2003;37:1475-1492.
2. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. HEPATOLOGY 2008;47:2089-2111.
3. Walshe JM, Yealland M. Chelation treatment of neurological Wilson's disease. Q J Med 1993;86:197-204.
4. Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 1987;44:490-493.
5. Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P. Oral zinc therapy for Wilson's disease. Ann Intern Med 1983;99:314-319.
6. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 1998;132:264-278.
7. Czlonkowska A, Gajda J, Rodo M. Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. J Neurol 1996;243:269-273.
8. Hoogenraad TU, van Hattum J, Van den Hamer CJ. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients. J Neurol Sci 1987;77:137-146.
9. Hoogenraad TU, Koevoet R, de Ruyter Korver EG. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979;18:205-211.
10. Hoogenraad TU. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 2006;28:141-146.
11. Wu ZY, Lin MT, Murong SX, Wang N. Molecular diagnosis and prophylactic therapy for presymptomatic Chinese patients with Wilson disease. Arch Neurol 2003;60:737-741.
12. Marcellini M, Di Clommo V, Callea F, Devito R, Comparcola D, Sartorelli MR, et al. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med 2005;145:139-143.
13. Alexiou D, Hatzis T, Koutselinis A. Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years. [in French] Arch Fr Pediatr 1985;42:447-449.
14. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 1957;2:200-215.
15. van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, Hoogenraad TU, Mali WP. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 1996;198:531-536.
16. Medici V, Trevisan CP, D'Inca R, Barollo M, Zancan L, Fagiuoli S, et al. Diagnosis and management of Wilson's disease: results of a single center experience. J Clin Gastroenterol 2006;40:936-941.
17. Wiggelinkhuizen M, Tilanus ME, Bollen CW, Houwen RH. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009;29:947-958.